These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 4479806

  • 1. [Effect of renal insufficiency and hemodialysis on cephacetrile pharmacokinetics].
    Nissenson AR, Levin NW, Parker RH.
    Arzneimittelforschung; 1974 Sep; 24(9b):1470-3. PubMed ID: 4479806
    [No Abstract] [Full Text] [Related]

  • 2. [The course of serum levels of a new cephalosporin, cephacetrile, as a function of renal elimination capacity].
    Brogard JM, Ruscher H, Frankhauser J, Kuntzmann F, Lavillaureix J.
    Arzneimittelforschung; 1974 Sep; 24(9b):1491-7. PubMed ID: 4479810
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of a new cephalosporin, cephacetrile, in patients with normal and impaired renal function.
    Westenfelder SR, Naber KG, Madsen PO.
    Arzneimittelforschung; 1974 Sep; 24(9b):1481-5. PubMed ID: 4479808
    [No Abstract] [Full Text] [Related]

  • 4. [The elimination of the antibiotic cephacetrile in patients with impaired renal function].
    Spring P, Räber J, Reber H, Dettli L.
    Arzneimittelforschung; 1974 Sep; 24(9b):1462-6. PubMed ID: 4479803
    [No Abstract] [Full Text] [Related]

  • 5. Renal handling and lymph concentration of two cephalosporin analogues, cephacetrile and cephaloridine. An experimental study in dogs.
    Naber KG, Madsen PO.
    Arzneimittelforschung; 1974 Sep; 24(9b):1485-91. PubMed ID: 4479809
    [No Abstract] [Full Text] [Related]

  • 6. [Antibacterial activity, pharmacokinetics and clinical use of a new cephalosporin antibiotic cephacetrile].
    Brogard JM, Kuntzmann F, Lavillaureix J.
    Arzneimittelforschung; 1974 Sep; 24(9b):1528-33. PubMed ID: 4479819
    [No Abstract] [Full Text] [Related]

  • 7. [Administration of cephalothin and cephloridine in uremic patients with hemodialysis].
    Takayasu H, Kitagawa R, Miyamura R, Koiso K, Kano S.
    Saishin Igaku; 1971 Jun; 26(6):1173-7. PubMed ID: 5098182
    [No Abstract] [Full Text] [Related]

  • 8. Effect of renal failure and hemodialysis on cephacetrile pharmacokinetics.
    Nissenson AR, Levin NW, Parker RH.
    Clin Pharmacol Ther; 1972 Jun; 13(6):887-94. PubMed ID: 5081601
    [No Abstract] [Full Text] [Related]

  • 9. [Plasma half-life of cefazoline. Study in the normal subject and in the patient with renal insufficiency].
    Humbert G, Fillastre JP, Leroy A.
    Nouv Presse Med; 1975 Oct 18; 4(35):2523-6. PubMed ID: 1196876
    [No Abstract] [Full Text] [Related]

  • 10. [Serum levels of a new cephalosporin, cephacetrile, as a function of renal excretion capacity].
    Brogard JM, Ruscher H, Frankhauser J, Kuntzmann F, Lavillaureix J.
    Pathol Biol (Paris); 1973 Jun 18; 21(6):671-9. PubMed ID: 4581199
    [No Abstract] [Full Text] [Related]

  • 11. [Comparative study on the concentration of cephacetrile and cephalothin in normal and chronically inflamed bone tissue].
    Hierholzer G, Linzenmeier G, Kleining R, Hörster G.
    Arzneimittelforschung; 1974 Sep 18; 24(9b):1501-4. PubMed ID: 4479811
    [No Abstract] [Full Text] [Related]

  • 12. Contribution to the pharmacokinetics of a new cephalosporin derivative.
    Dvorácek K, Modr Z, Schmidt O, Necásková A.
    Arzneimittelforschung; 1974 Sep 18; 24(9b):1468-70. PubMed ID: 4479805
    [No Abstract] [Full Text] [Related]

  • 13. Cefazolin vs cephalothin and cephaloridine. A comparison of their clinical pharmacology.
    Regamey C, Gordon RC, Kirby WM.
    Arch Intern Med; 1974 Mar 18; 133(3):407-10. PubMed ID: 4811478
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of a new cephalosporin, cephacetrile, in patients with normal and impaired renal function.
    Westenfelder SR, Naber KG, Madsen PO.
    Infection; 1973 Mar 18; 1(3):157-62. PubMed ID: 4597098
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of intravenous cefotaxime in patients undergoing chronic hemodialysis.
    Chodos J, Francke EL, Saltzman M, Neu HC.
    Ther Drug Monit; 1981 Mar 18; 3(1):71-4. PubMed ID: 6262952
    [Abstract] [Full Text] [Related]

  • 16. [Copper and zinc metabolic derangement in patients with chronic pyelonephritis developing nephrosclerosis and renal insufficiency].
    Pavlov SB.
    Urol Nefrol (Mosk); 1998 Mar 18; (1):7-9. PubMed ID: 9532935
    [Abstract] [Full Text] [Related]

  • 17. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S, Orlando R, Bertoli M, Pegoraro P, Palatini P.
    Clin Pharmacol Ther; 2006 Dec 18; 80(6):597-606. PubMed ID: 17178261
    [Abstract] [Full Text] [Related]

  • 18. [Study of total body potassium in patients with chronic renal insufficiency. Influence of dialysis].
    Delwaide PA, Rorive G.
    Nephron; 1971 Dec 18; 8(2):173-90. PubMed ID: 5000904
    [No Abstract] [Full Text] [Related]

  • 19. [Plasmatic half-life of a new cephalosporin in a patient with chronic renal insufficiency].
    Humbert G, Malandain H, Acar J, Fillastre JP.
    Nouv Presse Med; 1972 May 20; 1(21):1438. PubMed ID: 5036700
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of cephalosporins in patients with normal or reduced renal function.
    Andriole VT.
    J Infect Dis; 1978 May 20; 137 Suppl():S88-S99. PubMed ID: 349098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.